Consolidation of multiple technologies in applying a unique humanized anti-CD147 for cancer immunotherapy

มีนาคม 16, 2025
Chiang Mai University

Research Topics Consolidation of multiple technologies in applying a unique humanized anti-CD147 for cancer immunotherapy Researchers Prof. Chatchai TayapiwatanaAssist. Prof. Umpa YasamutAssist. Prof. Nutjeera IntasaiAssist. Prof. Weeraya ThongkumaAssist. Prof....

อ่านต่อไป

Prototype of industrial-scale production and efficacy validation of interferon gamma mutants for registration as a biologic drug for adult-onset immunodeficiency patients

มีนาคม 16, 2025
Chiang Mai University

Image by Tomislav Jakupec from Pixabay Research Topics Prototype of industrial-scale production and efficacy validation of interferon gamma mutants for registration as a biologic drug for adult-onset immunodeficiency patients Researchers Prof. Chatchai...

อ่านต่อไป

Advancing antibody engineering by integrating molecular biotechnology, molecular dynamic simulation and artificial intelligence

มีนาคม 16, 2025
Chiang Mai University

Research Topics Advancing antibody engineering by integrating molecular biotechnology, molecular dynamic simulation and artificial intelligence Researchers Prof. Chatchai TayapiwatanaAssist. Prof. Umpa YasamutAssist. Prof. Nutjeera IntasaiAssist. Prof. Weeraya ThongkumaAssist. Prof....

อ่านต่อไป

Center of Biomolecular Therapy and Diagnostics (CBTD), Faculty of Associated Medical Sciences, Chiang Mai University

มีนาคม 15, 2025
Chiang Mai University

Center of Biomolecular Therapy and Diagnostics (CBTD), Faculty of Associated Medical Sciences, Chiang Mai University For more details, please visit their:Official website: https://research.ams.cmu.ac.th/site/article?id=211Facebook page: – Facebook Twitter Line

อ่านต่อไป

Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study

มกราคม 25, 2025
จุฬาลงกรณ์มหาวิทยาลัย

Researchers from Chulalongkorn University have developed a new weapon against glioblastoma, a notoriously difficult-to-treat brain cancer, in the form of a brand-new antibody. This antibody is a key component...

อ่านต่อไป

The 29th Annual Meeting of Japanese Association of Cancer Immunology

Nagoya, Japan – The Japanese Association of Cancer Immunology (JACI) will host its 29th Annual Meeting from July 24th-26th, 2025, at WINC AICH, Nagoya, Japan. This marks the first...

อ่านต่อไป

A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement

มกราคม 10, 2025
Member Content

Recorded VDO

อ่านต่อไป

Enhancing Therapeutic Antibody Design with Computational Tools

มกราคม 7, 2025
Chiang Mai University

Scientists are using advanced computer programs to design better therapeutic antibodies. These antibodies are crucial for treating various diseases, but sometimes, the patient’s body sees them as foreign and...

อ่านต่อไป

Optimizing Humanness of Therapeutic Antibodies

มกราคม 7, 2025
Chiang Mai University

Scientists have been working to improve therapeutic antibodies, which are important tools for treating diseases like cancer and autoimmune disorders. A key challenge is making these antibodies less likely...

อ่านต่อไป

Prince Mahidol Award Youth Program (PMAYP) Conference 2025

Prince Mahidol Award Youth Program Conference 2025 Focuses on Immunotherapy in Solid TumorsBangkok, Thailand The Prince Mahidol Award Youth Program Conference 2025 will take place on January 28, 2025,...

อ่านต่อไป